BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33103371)

  • 21. OGDH mediates the inhibition of SIRT5 on cell proliferation and migration of gastric cancer.
    Lu X; Yang P; Zhao X; Jiang M; Hu S; Ouyang Y; Zeng L; Wu J
    Exp Cell Res; 2019 Sep; 382(2):111483. PubMed ID: 31247190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ubiquitin ligase CHIP functions as an oncogene and activates the AKT signaling pathway in prostate cancer.
    Cheng L; Zang J; Dai HJ; Li F; Guo F
    Int J Oncol; 2018 Jul; 53(1):203-214. PubMed ID: 29693147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TAZ is overexpressed in prostate cancers and regulates the proliferation, migration and apoptosis of prostate cancer PC3 cells.
    Lin M; Bu C; He Q; Gu J; Wang H; Feng N; Jiang SW
    Oncol Rep; 2020 Aug; 44(2):747-756. PubMed ID: 32468018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
    Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
    Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.
    Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y
    Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SIRT5 inhibits bovine preadipocyte differentiation and lipid deposition by activating AMPK and repressing MAPK signal pathways.
    Hong J; Mei C; Raza SHA; Khan R; Cheng G; Zan L
    Genomics; 2020 Mar; 112(2):1065-1076. PubMed ID: 31816429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioinformatics Analysis and Competitive Regulation by Transcription Factors of
    Hong J; Mei C; Wang X; Cheng G; Zan L
    DNA Cell Biol; 2018 Dec; 37(12):1003-1015. PubMed ID: 30300564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology.
    Kumar S; Lombard DB
    Crit Rev Biochem Mol Biol; 2018 Jun; 53(3):311-334. PubMed ID: 29637793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sirtuin 5 is Anti-apoptotic and Anti-oxidative in Cultured SH-EP Neuroblastoma Cells.
    Liang F; Wang X; Ow SH; Chen W; Ong WC
    Neurotox Res; 2017 Jan; 31(1):63-76. PubMed ID: 27577743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.
    Dang S; Zhou J; Wang Z; Wang K; Dai S; He S
    Biomed Pharmacother; 2018 Oct; 106():966-975. PubMed ID: 30170358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reciprocal regulation of long noncoding RNAs THBS4‑003 and THBS4 control migration and invasion in prostate cancer cell lines.
    Liu J; Cheng G; Yang H; Deng X; Qin C; Hua L; Yin C
    Mol Med Rep; 2016 Aug; 14(2):1451-8. PubMed ID: 27357608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway.
    Kim EJ; Juhnn YS
    J Biol Chem; 2015 Apr; 290(15):9604-13. PubMed ID: 25713071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SIRT5-mediated deacetylation of LDHB promotes autophagy and tumorigenesis in colorectal cancer.
    Shi L; Yan H; An S; Shen M; Jia W; Zhang R; Zhao L; Huang G; Liu J
    Mol Oncol; 2019 Feb; 13(2):358-375. PubMed ID: 30443978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR4 siRNA inhibits proliferation and invasion in colorectal cancer cells by downregulating ACAT1 expression.
    Ye K; Wu Y; Sun Y; Lin J; Xu J
    Life Sci; 2016 Jun; 155():133-9. PubMed ID: 27177773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
    Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
    BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging Roles for SIRT5 in Metabolism and Cancer.
    Bringman-Rodenbarger LR; Guo AH; Lyssiotis CA; Lombard DB
    Antioxid Redox Signal; 2018 Mar; 28(8):677-690. PubMed ID: 28707979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The bicyclic intermediate structure provides insights into the desuccinylation mechanism of human sirtuin 5 (SIRT5).
    Zhou Y; Zhang H; He B; Du J; Lin H; Cerione RA; Hao Q
    J Biol Chem; 2012 Aug; 287(34):28307-14. PubMed ID: 22767592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
    Cai J; Shen G; Liu S; Meng Q
    Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation and Purification of Catalytically Active Recombinant Sirtuin5 (SIRT5) Protein.
    Kumar S; Lombard DB
    Methods Mol Biol; 2016; 1436():241-57. PubMed ID: 27246219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer.
    Lu W; Zuo Y; Feng Y; Zhang M
    Tumour Biol; 2014 Nov; 35(11):10699-705. PubMed ID: 25070488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.